Vialwire

Vialwirebiotech, curated

September 30, 2026, 3:44 PM

August 29, 2026

3:32 AM · STAT News
3:32 AMSTAT+: A Novartis drug cut inflammation. Can it improve heart outcomes? — STAT News

August 28, 2026

2:00 PM · Pharmaceutical Executive
2:00 PM<![CDATA[Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals]]> — Pharmaceutical Executive
12:00 PM · BioWorld
12:00 PMDualitybio’s ADC efforts draw Roche in potential $1B deal — BioWorld
12:00 PM · BioWorld
12:00 PMBioxcel files for chapter 11, Teva bids on Igalmi for up to $125M — BioWorld
12:00 PM · BioWorld
12:00 PMTezspire Crossing to EoE? Astrazeneca, Amgen say phase III a win — BioWorld
11:59 AM · BioPharma Dive
11:59 AMModerna raises $2.6B to support cancer work; FDA clears updated COVID vaccines — BioPharma Dive
9:55 AM · Pharmaceutical Executive
9:55 AM<![CDATA[FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes ]]> — Pharmaceutical Executive
9:16 AM · PharmaVoice
9:16 AMA single drug made Argenx one of the most valuable biotechs in Europe. Its new CEO is ready for the next act. — PharmaVoice
9:00 AM · BioWorld
9:00 AMGates Foundation funding to support Profound’s work in women’s health — BioWorld
9:00 AM · BioWorld
9:00 AMCSPC Pharmaceutical obtains approval for SYH-2092 clinical trials in China — BioWorld
9:00 AM · BioWorld
9:00 AMFDA clears Adicet Bio’s IND for ADI-212 — BioWorld
6:42 AM · Pharmaceutical Technology
6:42 AMFDA approves Priovant’s rare autoimmune therapy Lisraya in indication first — Pharmaceutical Technology
6:41 AM · Pharmaceutical Technology
6:41 AMMSD’s Lipfendra takes on injectable rivals for cholesterol-lowering market supremacy — Pharmaceutical Technology
6:15 AM · STAT News
6:15 AMSTAT+: Cytokinetics details trial win for what could be its next approval — STAT News
5:36 AM · Pharmaceutical Technology
5:36 AMAusperBio raises $120m to progress hepatitis B therapies — Pharmaceutical Technology
5:23 AM · STAT News
5:23 AMSTAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs — STAT News
5:04 AM · Drug Discovery World
5:04 AMPanthera clinical research network expands to Keele University — Drug Discovery World
4:56 AM · Pharmaceutical Technology
4:56 AMFDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911 — Pharmaceutical Technology
12:00 AM · FT — Pharmaceuticals
12:00 AMBig Pharma steps up fight against counterfeit weight-loss drugs — FT — Pharmaceuticals

August 27, 2026

5:42 PM · Bloomberg — Technology
5:42 PMAgilent CEO on 3Q Earnings, Life Sciences Outlook — Bloomberg — Technology

← Newerpage 17Older →